Influenza targets

US8933046B2 · kind B2 · utility

Assignee

• Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V. · US

Inventors

• Nikolaus Machuy · Hamburg, DE
• Alexander Karlas · Berlin, DE
• Thomas F. Meyer · Tübingen, DE

Key dates

• Filing date: Dec 22, 2010
• Grant date: Jan 13, 2015
• Expiry date: Dec 22, 2030

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2500/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a pharmaceutical composition comprising an inhibitor of influenza virus replication. Yet another aspect is a screening method for identification of new targets for the prevention, alleviation or/and treatment of influenza.